JPMorgan Europe Research Enhanced Index Equity Active (ETR:JREE)
Germany · Delayed Price · Currency is EUR 52.35
+0.81 (1.57%)
Apr 30, 2026, 5:35 PM CET
18.80% (1Y)
| Assets | 2.61B |
| Expense Ratio | 0.25% |
| PE Ratio | 10.22 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +18.80% |
| Volume | 4,634 |
| Open | 51.29 |
| Previous Close | 51.54 |
| Day's Range | 51.29 - 52.36 |
| 52-Week Low | 43.84 |
| 52-Week High | 54.27 |
| Beta | 0.99 |
| Holdings | 157 |
| Inception Date | Oct 10, 2018 |
About JREE
The Sub-Fund aims to achieve a long-term return in excess of MSCI Europe Index (Total Return Net) (the "Benchmark") by actively investing primarily in a portfolio of European companies.
Asset Class Equity
Category Total Market
Stock Exchange Deutsche Börse Xetra
Ticker Symbol JREE
Provider JPMorgan
Performance
JREE had a total return of 18.80% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.84%.
Top 10 Holdings
23.79% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.37% |
| AstraZeneca PLC | AZN | 2.86% |
| Shell plc | SHEL | 2.77% |
| Nestlé S.A. | NESN | 2.19% |
| HSBC Holdings plc | HSBA | 2.12% |
| Novartis AG | NOVN | 2.05% |
| Allianz SE | ALV | 1.97% |
| Roche Holding AG | ROP | 1.96% |
| Siemens Aktiengesellschaft | SIE | 1.81% |
| Banco Santander, S.A. | SAN | 1.69% |